Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the “Global Advanced Dermatology Drug Delivery Devices Market- by Product (Injectors, Disposable Injectors, Reusable Injectors, Wearable Injectors, Patches, Microneedle Patches, Solid Removable Microneedles, Coated Microneedles, Dissolving Microneedles, Hollow Microneedles, Hydrogel Forming Microneedles, Needle-Less Patches, Dermal Pumps, Airless Dispensers and Bottles, Valves and Other Devices), Sales Channel (B2B Sales Channel and B2C Sales Channel), End-User (Hospitals, Dermatology Practices and Home Use), Trends, Industry Competition Analysis, Revenue and Forecast To 2030.”
According to the latest research by Insightace Analytics, the global Advanced Dermatology Drug Delivery Devices market was valued at US$ 4.31 Billion in 2021. It is expected to reach US$ 9.60 Billion by 2030, with a CAGR of 9.4% during a forecast period of 2022-2030.
Drug administration through the skin using needle-and-syringe combinations is not a novel idea, and it has been practised for decades. Advanced dermatology drug delivery systems are built on the idea of drug delivery with features for increased consumer involvement, improved medication adherence, user-friendly design, pain reduction, and ease of administration. Some gadgets include injectors, patches, airless bottles and dispensers, valves, dermal pumps, and add-on devices for safety and improved connectivity. Despite being universally despised, needle-and-syringe combination items currently account for a sizable portion of the market. Most cutting-edge drug delivery systems incorporate at least one of the previously listed attributes to gain some of that share.
The push for connected devices, the rising number of business synergies between drug delivery device manufacturers and pharmaceutical companies that result in the launch of new combination products in the market, the growing emphasis on prescription/medication/patient adherence, and cutting-edge drug delivery technologies like microneedle patches are the main driving factors that are anticipated to accelerate the market’s growth. The global push for connected devices, rising business synergies with pharmaceutical firms, novel technologies in drug delivery, and growing emphasis on prescription adherence are among the factors propelling the market growth. Strict laws, worries about data privacy, and a substantial portion of developing nations’ populace unaware of modern dermatology drug delivery systems are some of the issues limiting the market’s growth. Creating a specific app store for pharmaceutical businesses, utilizing synergies to enter emerging countries, and creating low-cost gadgets to increase sales in price-sensitive areas are potential opportunities to spur the market’s growth.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Over the forecast years, Europe is anticipated to contribute to the significantly advanced dermatology drug delivery devices market. As one of the future top markets for sophisticated dermatology drug delivery systems, Europe is a market for early adopters of innovative devices. Connected devices have gained popularity in Europe due to their advantages over conventional methods, including improved patient care and safety, shorter hospital stays, and quicker recovery. In addition, the North American advanced dermatology drug delivery devices market is expected to grow significantly. North American healthcare systems are among the most cutting-edge in the world regarding technology. The region is the world’s largest market for these devices and has many early adopters of advanced dermatology medicine delivery systems.
Major market players operating in the advanced dermatology drug delivery devices market include 3M Company, Zosano Pharma Corporation, Raphas Co., Ltd., Nanopass Tech, Corium International, Inc., Valeritas, Inc., Nitto Denko Corporation, Microder